Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net loss	$ (819)	$ (1,329)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation and amortization	162	283
Amortization of debt discount and deferred financing costs	5	0
Stock-based employee compensation	151	186
Restricted stock expense	0	(1)
Series C Preferred Shares issued for services	0	(97)
Series C Preferred issued in settlement of indemnity claim	417	0
Common Stock received as settlement of 16b claim	(325)	0
Loss on derivative liability	8	73
Forfeiture of restricted stock issued in lieu of salary	0	(16)
Changes in operating assets and liabilities:
Accounts receivable, net	74	2
Prepaid expenses and other assets	(23)	(6)
Accounts payable	65	90
Accrued Compensation	36	(159)
Other accrued liabilities	(104)	(24)
Deferred revenue	20	(99)
Net cash used in operating activities	(333)	(901)
Cash flows from investing activities:
Acquisition of property and equipment	0	(13)
Capitalized software development costs	0	(12)
Net cash used in investing activities	0	(25)
Cash flows from financing activities:
Net proceeds from issuance of Series C preferred shares	0	690
Net proceeds from issuance of short-term debt	125	0
Proceeds from exercise of warrants for cash	213	0
Proceeds from exercise of stock options	9	0
Net cash provided by financing activities	347	690
Effect of exchange rate changes on cash and cash equivalents	1	0
Net decrease in cash and cash equivalents	15	(236)
Cash and cash equivalents at beginning of period	307	1,879
Cash and cash equivalents at end of period	322	1,643
Supplemental disclosure of cash flow information:
Interest paid	0	0
Income tax paid	0	0
Non-cash financing and investing transactions:
Dividends on preferred shares	91	0
Accretion of beneficial conversion feature on Preferred Shares	659	3,501
Issuance of preferred shares by payment of dividends in kind	0	279
Fee warrants issued in connection with the March 31, 2011 issuance of the Series C Preferred shares	0	4
Cashless exercise of warrants	202	0
Conversion of Series B Preferred Stock into Common Stock	$ 140	$ 0